Replimune REPL
NASDAQ REPL
$15.03 -0.26 (-1.70%)
As of: Sep 4, 2026 · 2:31 PM EDT

Replimune (REPL) Capital Leases (2019 - 2026)

Replimune (REPL) posted Capital Leases of $21.9 million for Q1 2026, down 0.99% sequentially from $22.1 million in Q4 2025, and down 3.61% YoY from $22.7 million in Q1 2025.

Analysis

Replimune (REPL) Capital Leases (2019 - 2026) Analysis & Trends

Replimune has reported Capital Leases for 8 years, with the latest figure at $21.9 million in Q1 2026.

  • Quarterly Capital Leases fell 3.61% year-over-year to $21.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.9 million (down 3.61% YoY) and the FY2026 annual result came in at $21.9 million, down 3.61% from the prior year.
  • Capital Leases retreated to $21.9 million in Q1 2026 per REPL's latest filing, from $22.1 million in the prior quarter.
  • Over five years, Capital Leases peaked at $24.4 million in Q1 2022 and troughed at $21.9 million in Q1 2026.
  • A 5-year average of $23.3 million and a median of $23.4 million in 2024 frame the typical range for Capital Leases.
  • The sharpest annual moves came in 2022 and 2026: Capital Leases fell 1.37% in 2022, then slipped 3.61% in 2026.
  • Over 5 years, Capital Leases stood at $24.1 million in 2022, then dropped by 2.18% to $23.6 million in 2023, then fell by 2.75% to $22.9 million in 2024, then retreated by 3.42% to $22.1 million in 2025, then retreated by 0.99% to $21.9 million in 2026.
  • According to Business Quant data, Capital Leases over the past three periods registered $21.9 million, $22.1 million, and $22.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.50 Bn 77.51 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.06 Bn 52.92 Bn 52.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn -
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn
8 Royalty Pharma 28.41 Bn 27.57 Bn -
9 Insmed 27.42 Bn 26.26 Bn 358.27 Mn
10 Replimune 1.45 Bn 1.45 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 21.69 Mn
Mar 31, 2026 21.91 Mn
Dec 31, 2025 22.13 Mn
Sep 30, 2025 22.34 Mn
Jun 30, 2025 22.54 Mn
Mar 31, 2025 22.73 Mn
Dec 31, 2024 22.91 Mn
Sep 30, 2024 23.09 Mn
Jun 30, 2024 23.26 Mn
Mar 31, 2024 23.41 Mn
Dec 31, 2023 23.56 Mn
Sep 30, 2023 23.71 Mn
Jun 30, 2023 23.84 Mn
Mar 31, 2023 23.97 Mn
Dec 31, 2022 24.09 Mn
Sep 30, 2022 24.21 Mn
Jun 30, 2022 24.31 Mn
Mar 31, 2022 24.41 Mn
Dec 31, 2021 24.50 Mn
Sep 30, 2021 24.59 Mn